Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) announced earnings for its full year that Increased, from the same period last year
The company's bottom line totaled RMB120.285 million, or RMB0.0634 per share. This compares with RMB101.381 million, or RMB0.0533 per share, last year.
The company's revenue for the period fell 6.8% to RMB5.619 billion from RMB6.032 billion last year.
Guizhou Xinbang Pharmaceutical Co., Ltd. earnings at a glance (GAAP) :
-Earnings: RMB120.285 Mln. vs. RMB101.381 Mln. last year.-EPS: RMB0.0634 vs. RMB0.0533 last year.-Revenue: RMB5.619 Bln vs. RMB6.032 Bln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.